Navigation Links
Medical Device Developer Promaxo Closes $3.5 Million Series A Funding Round
Date:9/27/2017

Promaxo, Inc., a medical device company developing and commercializing a single-sided MRI, announced today that it has closed a $3.5 million Series A funding, with MicroPort Scientific Corporation as the strategic investor leading the round. As part of the strategic investment, MicroPort will secure exclusive China distribution rights and manufacturing rights of Promaxo’s MRI technology to support China commercialization.

Promaxo will use the new capital, together with $1.4 million in seed funding raised earlier this year, to perform clinical validation and prepare regulatory submission of its office-based high-resolution MRI. The Company’s MRI platform is protected by 33 issued and pending patents, and has been awarded over $9 million in NIH and NSF grants.

Once brought to market, Promaxo’s suite of prostate cancer disease management solutions will transform the screening, diagnosis and treatment of prostate cancer, and improve the lives of millions of men affected by the disease. A video highlighting the Promaxo story and solution is available at: https://youtu.be/AnGAwM2LlkQ

“We are thrilled to have MicroPort on board as a strategic investor and partner,” stated Promaxo’s CEO and President Amit Vohra, PhD, MBA. “The partnership will allow us to leverage MicroPort’s brand, talents, and global footprint to scale Promaxo’s MRI platform, and bring an office-based MRI to the masses.”

In a separate but related announcement, as part of its strategic growth plan, Promaxo has recently added Diego Olego, PhD, MBA, to the Company’s advisory team. Dr. Olego joined Philips in 1986, and over a career spanning more than three decades held several leadership positions in research, technology and innovation management, including Chief Strategy and Innovation Officer of Philips Healthcare.

"I am excited to be joining the Promaxo team,” stated Dr. Olego. “I believe that Promaxo's mobile innovative MR platform promises broad clinical and workflow impact, especially for prostate cancer patients."

For more information visit http://www.promaxo.com or email hello(at)promaxo.com.

About Promaxo Inc.

Promaxo is developing and commercializing office-based high-resolution MRI, real time MRI compatible biopsy and treatment tools, and CAD software for tissue characterization. The company is currently focused on transforming the screening, diagnosis and treatment of prostate cancer.

Read the full story at http://www.prweb.com/releases/2017/09/prweb14733715.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. In’Tech Medical Unveils New Branding Initiative
2. Velico Medical Announces a Further $18.9m BARDA Funding for Spray Dried Alternative to Frozen Plasma
3. Vixiar Medical Taking up Residence at The LaunchPort™ in Port Covington
4. Varicose Veins Myths Highlight the Importance of Understanding Medical Options, says Northwest Vein & Aesthetic Center
5. Pacific Neuroscience Institute Medical Group Joins Providence Saint Johns Health Clinic For Greater Access to Care of Neurological and Cranial Disorders
6. Novel Medical Device Manufacturing Operation and Accelerator Coming to Port Covington
7. Omnia Education Expands its Live Medical Conferences by Adding New U.S. Cities, New Faculty, Interactive Educational Games, and Cutting Edge Clinical Topics
8. CNA Finance Initiates Research Coverage On Advanced Medical Isotope Corporation
9. Brian Pogue Named Editor of Journal of Biomedical Optics
10. Lutheran Medical Center Recognized in Fierce Innovation Awards in Healthcare for its Implementation of BIOVIGIL
11. Kapstone Medical Celebrates 10th Anniversary
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... platform specifically designed for life science researchers to analyze and interpret datasets, ... Franklin, who made a major contribution to the discovery of the double-helix ...
(Date:10/11/2017)... ... 11, 2017 , ... The CRISPR-Cas9 system has ... and avoiding the use of exogenous expression plasmids. The simplicity of programming this ... gain-of-function studies. , This complement to loss-of-function studies, such as with RNAi ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is ... and 8th June 2018 in San Francisco, CA. The Summit brings together current and ... distinguished CEOs, board directors and government officials from around the world to address key ...
(Date:10/11/2017)... -- VMS BioMarketing, a leading provider of patient support solutions, has ... (CNE) network, which will launch this week. The VMS CNEs ... professionals to enhance the patient care experience by delivering peer-to-peer ... care professionals to help women who have been diagnosed and ... ...
Breaking Biology Technology:
(Date:4/11/2017)... MELBOURNE, Florida , April 11, 2017 ... "Company"), a security technology company, announces the appointment of independent ... John Bendheim to its Board of Directors, furthering the ... ... behalf of NXT-ID, we look forward to their guidance and ...
(Date:4/5/2017)... -- The Allen Institute for Cell Science today announces the ... and dynamic digital window into the human cell. The ... of deep learning to create predictive models of cell ... growing suite of powerful tools. The Allen Cell Explorer ... available resources created and shared by the Allen Institute ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... to expand at a CAGR of 25.76% during the ... is the primary factor for the growth of the ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem ... technology, application, and geography. The stem cell market of ...
Breaking Biology News(10 mins):